← Back to Search

Working to Implement and Sustain Digital Outcome Measures (WISDOM Trial)

N/A

Waitlist Available

Led By Nate Williams, PhD

Research Sponsored by Boise State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0-18 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if improving clinic leadership and organization helps youth mental health clinics better use a digital tool to track patient progress. The goal is to see if this leads to better care for young patients.

Eligible Conditions

Psychiatric and Behavioural Symptoms
Implementation
Behavioral Symptoms

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0-18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0-18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change From Baseline to 6-months in Youth Total Problems Score on the Short Form Assessment for Children (SAC) - Phase I Cohort

Change From Baseline to 6-months in Youth Total Problems Score on the Short-form Assessment for Children (SAC) - Phase II Cohort

Percentage Fidelity to the OQ-A System Experienced by the Youth (0-100%)

Secondary study objectives

Change from Baseline in Clinic Implementation Climate for OQ-A

Change from Baseline in First-level Leaders' Implementation Leadership (ILS)

Change from Baseline in First-level Leaders' Transformational Leadership (MLQ)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: LOCI (Intervention)Experimental Treatment2 Interventions

In clinics assigned to the LOCI condition, executives and first-level leaders will receive leadership training and coaching to support implementation of the OQ-A system. In addition, leaders and clinicians in this condition will receive training and technical assistance to implement the OQ-A measurement-based care system.

Group II: Training and Technical Assistance only (Control)Active Control1 Intervention

In clinics assigned to the control group, leaders and clinicians will receive training and technical assistance to implement the OQ-A measurement-based care system. In addition, to support enrollment in this condition, leaders in this condition will be offered access to general web-based leadership seminars.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Training and Technical Assistance Only

2019

N/A

~690

Leadership for Organization Change and Implementation (LOCI)

2019

N/A

~690